1. A compound represented by the following general formula (I):
Formula 1
(wherein,
R1, R2, R3, R4 and R5 are the same or different, and represent hydrogen atom, a halogen atom, a lower alkyl group, a halo(lower alkyl) group, a lower alkoxy group, a halo(lower alkoxy) group, hydroxy group, cyano group, nitro group, a (lower alkyl)thio group, a (lower alkyl)sulfinyl group, a (lower alkyl)sulfonyl group, a (lower alkyl)sulfonylamino group, a halo(lower alkyl)sulfonylamino group, an arylsulfonylamino group, an amino group which may have a substituent, carboxyl group, a (lower alkyl)carbonyl group, or a (lower alkoxy)carbonyl group,
R6 represents a lower alkyl group, a halo(lower alkyl) group, a lower cycloalkyl group, or a (lower cycloalkyl)(lower alkyl) group,
R7 and R8 are the same or different, and represent hydrogen atom, a lower alkyl group, a (lower cycloalkyl)(lower alkyl) group which may have a substituent, an aryl group, an aryl(lower alkyl) group which may have a substituent, or a lower cycloalkyl group, or R7 and R8 may combine to form a nitrogen-containing saturated heterocyclic ring which may have a substituent together with the adjacent nitrogen atom,
R9 represents hydrogen atom, a halogen atom, a lower alkoxy group, a (lower alkyl)thio(lower alkoxy) group, a (lower alkyl)sulfinyl(lower alkoxy) group, a (lower alkyl)sulfonyl(lower alkoxy) group, an aryl(lower alkoxy) group which may have a substituent, a (lower alkyl)amino group, a di(lower alkyl)amino group, a (lower alkyl)thio(lower alkyl)amino group, a (lower alkyl)sulfinyl(lower alkyl)amino group, a (lower alkyl)sulfonyl(lower alkyl)amino group, an arylamino group, a cyclic amino group which may have a hetero atom as a ring-constituting atom, a (lower alkoxy)(lower alkoxy) group, a (lower alkoxy)(lower alkyl)amino group, a hydroxy(lower alkoxy) group, a hydroxy(lower alkyl)amino group, an acylamino group, a (lower alkyl)sulfonylamino group, a hydroxycarbonyl(lower alkoxy) group, an amino(lower alkoxy) group, a (lower alkyl)amino(lower alkoxy) group, or a di(lower alkyl)amino(lower alkoxy) group,
R10 and R11 are the same or different, and represent hydrogen atom, a halogen atom, a lower alkyl group, a lower cycloalkyl group, a (lower cycloalkyl)(lower alkyl) group, a halo(lower alkyl) group, a lower alkoxy group, a halo(lower alkoxy) group, a (lower alkoxy)(lower alkoxy) group, hydroxy group, cyano group, nitro group, a (lower alkyl)thio group, a (lower alkyl)sulfinyl group, a (lower alkyl)sulfonyl group, a (lower alkyl)sulfonylamino group, a halo(lower alkyl)sulfonylamino group, an arylsulfonylamino group, an amino group which may have a substituent, carboxyl group, a (lower alkyl)carbonyl group, or a (lower alkoxy)carbonyl group,
represents a monocyclic or bicyclic heterocyclic ring having 6 to 10 ring-constituting atoms at least one of which is nitrogen atom, and
the general formula (I) represents both individual enantiomers and mixtures thereof) or a salt thereof, or a solvate thereof.
2. The compound or a salt thereof, or a solvate thereof according to claim 1, wherein R1, R2, R3, R4 and R5 are the same or different, and represent hydrogen atom, a halogen atom, a C1-C6 alkyl group, a halo(C1-C6 alkyl) group, a C1-C6 alkoxy group, a halo(C1-C6 alkoxy) group, or cyano group,
R6 represents a C1-C6 alkyl group, a halo(C1-C6 alkyl) group, a C3-C8 cycloalkyl group, or a (C3-C8 cycloalkyl)(C1-C6 alkyl) group,
R7 and R8 are the same or different, and represent a C1-C6 alkyl group, a (C3-C8 cycloalkyl)(C1-C6 alkyl) group which may have a hydroxycarbonyl(C1-C6 alkyl) group on the cycloalkyl ring as a substituent, or a (C6-C10 aryl)(C1-C6 alkyl) group which may have a C1-C6 alkoxy group on the aryl ring as a substituent, or R7 and R8 combine to form pyrrolidino group together with the adjacent nitrogen atom,
R9 represents a halogen atom, a (C1-C6 alkylthio(C1-C6 alkoxy) group, a (C1-C6 alkylsulfinyl(C1-C6 alkoxy) group, a (C1-C6 alkylsulfonyl(C1-C6 alkoxy) group, a (C6-C10 aryl)(C1-C6 alkoxy) group (this (C6-C10 aryl)(C1-C6 alkoxy) group may have a halogen atom, a halo(C1-C6 alkyl) group or cyano group on the aryl ring as a substituent), morpholinyl group or piperidinyl group,
R10 and R11 are the same or different, and represents hydrogen atom, a halogen atom, a C1-C6 alkyl group, a halo(C1-C6 alkyl) group or a C1-C6 alkoxy group, and
represents
3. The compound or a salt thereof, or a solvate thereof according to claim 1, wherein R1, R2, R3, R4 and R5 are the same or different, and represent hydrogen atom, a halo(C1-C6 alkyl) group, or cyano group,
R6 represents a C1-C6 alkyl group,
R7 and R8 are the same or different, and represent a C1-C6 alkyl group or a (C3-C8 cycloalkyl)(C1-C6 alkyl) group,
R9 represents a (C1-C6 alkyl)thio(C1-C6 alkoxy) group, a (C1-C6 alky)sulfinyl(C1-C6 alkoxy) group or a (C1-C6 alkylsulfonyl(C1-C6 alkoxy) group,
R10 and R11 are the same or different, and represent hydrogen atom, a C1-C6 alkyl group, a halo(C1-C6 alkyl) group or a C1-C6 alkoxy group, and
Formula 6
4. The compound or a salt thereof, or a solvate thereof according to claim 1, wherein the compound represented by the general formula (I) is:
N-{1-3,5-bis(trifluoromethyl)phenylethyl}-N-({3-(cyclopentylmethyl)(ethyl)amino-6-methoxypyridin-2-yl}methyl)-5-2-(methylthio)ethoxypyrimidin-2-amine,
N-{1-3,5-bis(trifluoromethyl)phenylethyl}-N-({3-(cyclopentylmethyl)(ethyl)amino-6-methoxypyridin-2-yl}methyl)-5-2-(methylsulfinyl)ethoxypyrimidin-2-amine,
N-{1-3,5-bis(trifluoromethyl)phenylethyl}-N-({3-(cyclopentylmethyl)(ethyl)amino-6-methoxypyridin-2-yl}methyl)-5-2-(methylsulfonyl)ethoxypyrimidin-2-amine,
5-({1-3,5-bis(trifluoromethyl)phenylethyl}{5-2-(methylthio)ethoxypyrimidin-2-yl}amino)methyl-N-(cyclopentylmethyl)-N-ethyl-1,3-dimethyl-1H-pyrazolo3,4-bpyridin-6-amine,
5-({1-3,5-bis(trifluoromethyl)phenylethyl}{5-2-(methylsulfonyl)ethoxypyrimidin-2-yl}amino)methyl-N-(cyclopentylmethyl)-N-ethyl-1,3-dimethyl-1H-pyrazolo3,4-bpyridin-6-amine,
3-({1-3,5-bis(trifluoromethyl)phenylethyl}{5-2-(methylthio)ethoxypyrimidin-2-yl}amino)methyl-N-(cyclopentylmethyl)-N-ethylquinolin-2-amine,
3-({1-3,5-bis(trifluoromethyl)phenylethyl}{5-2-(methylsulfonyl)ethoxypyrimidin-2-yl}amino)methyl-N-(cyclopentylmethyl)-N-ethylquinolin-2-amine,
3-({1-3,5-bis(trifluoromethyl)phenylethyl}{5-2-(methylthio)ethoxypyrimidin-2-yl}amino)methyl-N-(cyclopentylmethyl)-N-ethyl-6-methoxyquinolin-2-amine,
3-({1-3,5-bis(trifluoromethyl)phenylethyl} {5-2-(methylsulfonyl)ethoxypyrimidin-2-yl}amino)methyl-N-(cyclopentylmethyl)-N-ethyl-6-methoxyquinolin-2-amine,
3-({1-3,5-bis(trifluoromethyl)phenylethyl}{5-2-(methylthio)ethoxypyrimidin-2-yl}amino)methyl-N-(cyclopentylmethyl)-N-ethyl-6-trifluoromethylquinolin-2-amine,
3-({1-3,5-bis(trifluoromethyl)phenylethyl}{5-2-(methylsulfonyl)ethoxypyrimidin-2-yl}amino)methyl-N-(cyclopentylmethyl)-N-ethyl-6-trifluoromethylquinolin-2-amine,
3-({1-3,5-bis(trifluoromethyl)phenylethyl}{5-2-(methylthio)ethoxypyrimidin-2-yl}amino)methyl-N-(cyclopentylmethyl)-N-ethyl-6-methylquinolin-2-amine,
3-({1-3,5-bis(trifluoromethyl)phenylethyl}{5-2-(methylsulfonyl)ethoxypyrimidin-2-yl}amino)methyl-N-(cyclopentylmethyl)-N-ethyl-6-methylquinolin-2-amine,
N-{1-3,5-bis(trifluoromethyl)phenylethyl}-N-({2-(cyclopentylmethyl)(ethyl)amino-6-methylpyridin-3-yl}methyl)-5-2-(methylthio)ethoxypyrimidin-2-amine,
N-{1-3,5-bis(trifluoromethyl)phenylethyl}-N-({2-(cyclopentylmethyl)(ethyl)amino-6-methylpyridin-3-yl}methyl)-5-2-(methylsulfonyl)ethoxypyrimidin-2-amine,
N-{1-3,5-bis(trifluoromethyl)phenylethyl}-N-({2-(cyclopentylmethyl)(ethyl)amino-6-ethylpyridin-3-yl}methyl)-5-2-(methylthio)ethoxypyrimidin-2-amine,
N-{1-3,5-bis(trifluoromethyl)phenylethyl}-N-({2-(cyclopentylmethyl)(ethyl)amino-6-ethylpyridin-3-yl}methyl)-5-2-(methylsulfonyl)ethoxypyrimidin-2-amine,
N-{1-3,5-bis(trifluoromethyl)phenylethyl}-N-({2-(cyclopentylmethyl)(ethyl)amino-5,6-dimethylpyridin-3-yl}methyl)-5-2-(methylthio)ethoxypyrimidin-2-amine,
N-{1-3,5-bis(trifluoromethyl)phenylethyl}-N-({2-(cyclopentylmethyl)(ethyl)amino-5,6-dimethylpyridin-3-yl}methyl)-5-2-(methylsulfonyl)ethoxypyrimidin-2-amine,
3-({1-3,5-bis(trifluoromethyl)phenylpropyl}{5-2-(methylthio)ethoxypyrimidin-2-yl}amino)methyl-N-(cyclopentylmethyl)-N-ethylquinolin-2-amine,
3-({1-3,5-bis(trifluoromethyl)phenylpropyl}{5-2-(methylsulfonyl)ethoxypyrimidin-2-yl}amino)methyl-N-(cyclopentylmethyl)-N-ethylquinolin-2-amine,
3-{1-({6-(cyclopentylmethyl)(ethyl)amino-1,3-dimethyl-1H-pyrazolo3,4-bpyridin-5-yl}methyl){5-2-(methylthio)ethoxypyrimidin-2-yl}aminoethyl}-5-(trifluoromethyl)benzonitrile,
3-{1-({6-(cyclopentylmethyl)(ethyl)amino-1,3-dimethyl-1H-pyrazolo3,4-bpyridin-5-yl}methyl){5-2-(methylsulfonyl)ethoxypyrimidin-2-yl}aminoethyl}-5-(trifluoromethyl)benzonitrile,
N-{1-3,5-bis(trifluoromethyl)phenylethyl}-N-({3-(cyclopentylmethyl)(ethyl)aminopyrazin-2-yl}methyl)-5-2-(methylthio)ethoxypyrimidin-2-amine, or
N-{1-3,5-bis(trifluoromethyl)phenylethyl}-N-({3-(cyclopentylmethyl)(ethyl)aminopyrazin-2-yl}methyl)-5-2-(methylsulfonyl)ethoxypyrimidin-2-amine.
5. A medicament containing the compound or a salt thereof, or a solvate thereof according to any one of claims 1 to 4 as an active ingredient.
6. The medicament according to claim 5, which is a prophylactic andor therapeutic agent for a disease, hyperlipidemia, arteriosclerosis, atherosclerosis, peripheral vascular disease, abnormal lipidemia, hyper-LDL-emia, hypo-HDL-emia, hypercholesterolemia, hypertriglyceridemia, familial hypercholesterolemia, cardiovascular disturbance, angina pectoris, ischemia, cardiac ischemia, thrombosis, myocardial infarction, reperfusion disturbance, angioplasty restenosis, or hypertension.
7. A CETP inhibitor containing the compound or a salt thereof, or a solvate thereof according to any one of claims 1 to 4 as an active ingredient.
8. An HDL-increasing agent containing the compound or a salt thereof, or a solvate thereof according to any one of claims 1 to 4 as an active ingredient.
9. A pharmaceutical composition containing the compound or a salt thereof, or a solvate thereof according to any one of claims 1 to 4 and a pharmaceutically acceptable carrier.
10. A method for prophylactic andor therapeutic treatment of a disease, hyperlipidemia, arteriosclerosis, atherosclerosis, peripheral vascular disease, abnormal lipidemia, hyper-LDL-emia, hypo-HDL-emia, hypercholesterolemia, hypertriglyceridemia, familial hypercholesterolemia, cardiovascular disturbance, angina pectoris, ischemia, cardiac ischemia, thrombosis, myocardial infarction, reperfusion disturbance, angioplasty restenosis, or hypertension, which comprises the step of administering the compound or a salt thereof, or a solvate thereof according to any one of claims 1 to 4.
11. Use of the compound or a salt thereof, or a solvate thereof according to any one of claims 1 to 4 for the manufacture of a medicament for prophylactic andor therapeutic treatment of a disease, hyperlipidemia, arteriosclerosis, atherosclerosis, peripheral vascular disease, abnormal lipidemia, hyper-LDL-emia, hypo-HDL-emia, hypercholesterolemia, hypertriglyceridemia, familial hypercholesterolemia, cardiovascular disturbance, angina pectoris, ischemia, cardiac ischemia, thrombosis, myocardial infarction, reperfusion disturbance, angioplasty restenosis, or hypertension.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. Method for detecting missing components in a package comprising: generating a multiplicity of electrical outputs representing the mass in volumes of the package; combining the multiplicity of electrical outputs to arrive at a combined value; identifying a standard value of a package including all components; comparing the combined value with the standard value; and rejecting the package where the combined value does not meet the standard value.
2. The method of claim 1 wherein generating the multiplicity of electrical outputs comprises: radiating the package with an x-ray beam generated by an x-ray radiator; and detecting radiation passing through the package at spaced locations on the opposite side of the package than the x-ray radiator.
3. The method of claim 2 wherein the package is on a conveyor when radiated.
4. The method of claim 3 wherein the package is radiated by a fan shaped x-ray beam; wherein the radiation is detected by a line of detectors; and wherein the package is moved between the radiator and line of detectors to generate the multiplicity of electrical outputs.
5. The method of claim 4 wherein the multiplicity of outputs corresponds to the total volume of the package.
6. The method of claim 5 further comprising: displaying the combined value.
7. The method of claim 6 wherein the electrical outputs are numerical values.
8. The method of claim 7 wherein the electrical outputs represent the amount of radiation detected.
9. The method of claim 1 wherein the package is radiated by a fan shaped x-ray beam; wherein the radiation is detected by a line of detectors; and wherein the package is moved between the radiator and line of detectors to generate the multiplicity of electrical outputs.
10. The method of claim 1 wherein the multiplicity of outputs corresponds to the total volume of the package.
11. The method of claim 1 further comprising: displaying the combined value.
12. The method of claim 1 wherein the electrical outputs are numerical values.
13. The method of claim 1 wherein the electrical outputs represent the amount of radiation detected.
14. System for detecting missing components in a package comprising, in combination: means for radiating the package with an energy wave which is absorbable by the components in the package; means for detecting the energy passing through the package and for generating a multiplicity of electrical outputs representing the mass in volumes in the package; means for combining the multiplicity of electrical outputs to arrive at a combined value; means for comparing the combined value with a standard value for a package including all components; and means for rejecting the package where the combined value does not meet the standard value.
15. The system of claim 14 wherein the radiating means comprises an x-ray radiator.
16. The system of claim 15 wherein the x-ray radiator radiates a fan-shaped x-ray beam; and wherein the detecting means comprises a line of individual detectors, with the package being moved between the x-ray radiator and the line of detectors to generate the multiplicity of electrical outputs.
17. The system of claim 16 further comprising in combination: a conveyor for conveying the package between the radiating means and the detecting means, with the rejecting means removing the package from the conveyor.
18. The system of claim 17 further comprising, in combination: a counter type gauge to display the package value.
19. The system of claim 16 wherein the detecting means detects the level of energy remaining after passing through the package.
20. The system of claim 14 wherein the detecting means detects the level of energy remaining after passing through the package.